Posts Tagged: Paul Santerre
Paul Santerre, a professor in the Faculty of Dentistry and the Institute of Biomedical Engineering, says the extent of progress on diabetes and insulin will partly depend on how well research breakthroughs from scholars like Brubaker can be married with efforts at commercialization and innovation.
Paul Santerre receives lifetime achievement award from Canadian Biomaterials Society
Interface Biologics's (IBI) antithrombogenic additive have been used in a new line of FDA-approved "breakthrough" dialysis products made by IBI's partner, Fresenius Medical Care.
Multidisciplinary team awarded five year, $1M project grant to develop a new filling material
This U of T Engineering innovation makes implants safer, and is attracting new investment to Toronto
Global chemical company Evonik will maintain presence in Toronto after acquiring part of U of T spinoff Interface Biologics, Inc.
Cohesys, a biomedical device startup that makes biodegradable ‘bone tape’ to help heal facial fractures, recently took home US$20,000 at an international competition.
Meghan Wright received a Canada Graduate Scholarship and Michael Smith Foreign Study Supplement to spend six months at Harvard Medical School for research exchange.
Polumiros, co-founded by Kyle Battiston and Soror Sharifpoor, is developing a polymer to fill the cavities left in breast cancer patients following a lumpectomy.
Professors Paul Santerre and Craig Simmons will be receiving federal government support for their research aimed at addressing heart disease.
U of T biomedical engineering professor receives UHN support to drive commercialization and entrepreneurship opportunities for students and hospital trainees.
Showing 11 - 20 of 35 results